» Articles » PMID: 16381082

Using Simulation to Estimate the Cost Effectiveness of Improving Ambulance and Thrombolysis Response Times After Myocardial Infarction

Overview
Journal Emerg Med J
Specialty Emergency Medicine
Date 2005 Dec 29
PMID 16381082
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To quantify the health gains and costs associated with improving ambulance and thrombolysis response times for acute myocardial infarction.

Design: A computer simulation model. PATIENTS/SETTINGS: Patients experiencing acute myocardial infarction in England.

Interventions: Improving the ambulance response time to 75% of calls reached within 8 minutes and the hospital arrival to thrombolysis time interval (door-to-needle time) to 75% receiving it within 30 minutes and 20 minutes, compared to best estimates of response times in the mid-1990s.

Main Outcome Measures: Deaths prevented, life years saved, and discounted cost per life year saved.

Results: Improving the ambulance response to 75% of calls within 8 minutes resulted in an estimate of 5 deaths prevented or 57 life years saved per million population per year, with a discounted incremental cost per life year saved of 8540 pounds sterling over 20 years. The corresponding benefit of improving the door-to-needle time to 75% of myocardial infarction patients within 30 minutes was an estimated 2 deaths prevented and 15 life years saved per million population per year, with a discounted incremental cost per life year saved of between 10,150 pounds sterling to 54,230 pounds sterling over 20 years. Little further gain was associated with reaching the 20 minute target. Combining ambulance and thrombolysis targets resulted in 70 life years saved per million population per year.

Conclusions: Improving ambulance response times appears to be cost effective. Reducing door-to-needle time will have a smaller effect at an uncertain cost. Further benefits may be gained from reducing the time from onset of symptoms to starting thrombolysis.

Citing Articles

Can drones save lives and money? An economic evaluation of airborne delivery of automated external defibrillators.

Roper J, Fischer K, Baumgarten M, Thies K, Hahnenkamp K, Flessa S Eur J Health Econ. 2022; 24(7):1141-1150.

PMID: 36309919 PMC: 10406671. DOI: 10.1007/s10198-022-01531-0.


Decreased length of stay after addition of healthcare provider in emergency department triage: a comparison between computer-simulated and real-world interventions.

Day T, Al-Roubaie A, Goldlust E Emerg Med J. 2012; 30(2):134-8.

PMID: 22398851 PMC: 3582047. DOI: 10.1136/emermed-2012-201113.


Support and Assessment for Fall Emergency Referrals (SAFER 1) trial protocol. Computerised on-scene decision support for emergency ambulance staff to assess and plan care for older people who have fallen: evaluation of costs and benefits using a....

Snooks H, Cheung W, Close J, Dale J, Gaze S, Humphreys I BMC Emerg Med. 2010; 10:2.

PMID: 20102616 PMC: 2824628. DOI: 10.1186/1471-227X-10-2.


A review of health care models for coronary heart disease interventions.

Cooper K, Brailsford S, Davies R, Raftery J Health Care Manag Sci. 2006; 9(4):311-24.

PMID: 17186767 DOI: 10.1007/s10729-006-9996-x.

References
1.
Hemingway H, Crook A, Banerjee S, Dawson J, Feder G, Magee P . Hypothetical ratings of coronary angiography appropriateness: are they associated with actual angiographic findings, mortality, and revascularisation rate? The ACRE study. Heart. 2001; 85(6):672-9. PMC: 1729790. DOI: 10.1136/heart.85.6.672. View

2.
Qasim A, Malpass K, OGorman D, Heber M . Safety and efficacy of nurse initiated thrombolysis in patients with acute myocardial infarction. BMJ. 2002; 324(7349):1328-31. PMC: 1123280. DOI: 10.1136/bmj.324.7349.1328. View

3.
Pell J, Sirel J, Marsden A, Ford I, Cobbe S . Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study. BMJ. 2001; 322(7299):1385-8. PMC: 32251. DOI: 10.1136/bmj.322.7299.1385. View

4.
Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R . ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. BMJ. 1998; 316(7141):1337-43. PMC: 28530. DOI: 10.1136/bmj.316.7141.1337. View

5.
Cobbe S, Redmond M, Watson J, Hollingworth J, Carrington D . "Heartstart Scotland"--initial experience of a national scheme for out of hospital defibrillation. BMJ. 1991; 302(6791):1517-20. PMC: 1670199. DOI: 10.1136/bmj.302.6791.1517. View